Arcturus Therapeutics Holdings Overview
Arcturus Therapeutics Holdings Target Price
Analysts' 12-month price predictions for ARCT.
Get informed when a big investor buys or sells
+ FollowShare Price
$7.28
Average Target Price
$25.00
243.4% upside
243.4% upside1 analysts in the last 4 months
High: $25 | Low: $25
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-03-04 | Piper SandlerYasmeen Rahimi | $25 | 243.4% upside |  |
| 2026-01-22 | Roth Capital | $20 | 174.7% upside | |
| 2025-08-22 | Leerink PartnersLili Nsongo | $54 | 641.8% upside | |
| 2025-05-28 | ScotiabankGreg Harrison | $32 | 339.6% upside | |
| 2025-03-10 | BTIGThomas Shrader | $48 | 559.3% upside | |
| 2024-11-11 | Canaccord GenuityWhitney Ijem | $10.58 | 45.3% upside | |
| 2024-08-06 | Canaccord GenuityWhitney Ijem | $10.3 | 41.5% upside | |
| 2024-07-02 | H.C. WainwrightEd Arce | $8.58 | 17.9% upside | |
| 2024-05-31 | Piper SandlerYasmeen Rahimi | $20.02 | 175% upside | |
| 2024-05-10 | Canaccord GenuityWhitney Ijem | $12.3 | 69% upside | |
| 2024-03-19 | LaidlawYale Jen | $11.3 | 55.2% upside | |
| 2022-11-02 | BarclaysGena Wang | $25 | 243.4% upside | |
| 2022-05-11 | Goldman Sachs | $14 | 92.3% upside | |
| 2021-11-09 | Goldman SachsMadhu Kumar | $30 | 312.1% upside | |